Dissociation of TNF-α from endotoxin-induced nitric oxide and acute- phase hypotension

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 273, Issue 1 42-1, 1997, Pages

  Xie, Jianming ^a   Joseph, Kevin O ^a   Bagby, Greg J ^a   Giles, Thomas D ^a   Greenberg, Stan S ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Inducible nitric oxide synthase messenger ribonucleic acid; Mesenteric artery; Neutrophils; Platelet activating factor; Sepsis

Indexed keywords

ENDOTOXIN; MESSENGER RNA; NITRIC OXIDE; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CELL WALL; BLOOD VESSEL REACTIVITY; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME INDUCTION; ESCHERICHIA COLI; HOST RESISTANCE; HYPOTENSION; LUNG ALVEOLUS MACROPHAGE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; SEPSIS;

EID: 0030741236     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1997.273.1.h164     Document Type: Article

References (34)

1. Alexander, H. R., B. C. Sheppard, J. C. Jensen, H. N. Langstein, C. M. Buresh, D. Venzon, E. C. Walker, D. L. Fraker, M. C, Stovroff, and J. A. Norton. Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram-negative sepsis. J. Clin. Invest. 88: 34-39, 1991.
2. Arthur, J. F., S. Shahin, and G. J. Dusting. PAF antagonists block induction of nitric oxide synthase in cultured macrophages and vascular smooth muscle cells. Clin. Exp. Pharmacol. Physiol. 22: 452-454, 1995.
3. Bagby, G. J., K. J. Plessala, L. A. Wilson, J. J. Thompson, and S. Nelson. Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis. J. Infect. Dis. 163: 83-92, 1991.
4. Beutler, B., and G. E. Grau. Tumor necrosis factor in the pathogenesis of infectious disease. Crit. Care Med. 10: S423-S442, 1993.
5. Beutler, B., I. W. Milsark, and A. C. Cerami. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229: 869-872, 1985.
6. Busse, R., and A. Mulsch. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett. 275: 87-90, 1990.
7. Bussolino, F., G. Camussi, and C. Baglioni. Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1α. J. Biol. Chem. 263: 11856-11862, 1988.
8. Dal Nogare, A. R. Septic shock. Am. J. Med. Sci. 302: 50-65, 1991.
9. De Kimpe, S. J., C. Thiemermann, and J. R. Vane. Role for intracellular platelet-activating factor in the circulatory failure in a model of Gram-positive shock. Br. J. Pharmacol. 116: 3191-3198, 1995.
10. Emerson, T. E., Jr., D. C. Lindsey, G. J., Jesmok, M. L. Duerr, and M. A. Fournel. Efficacy of monoclonal antibody against tumor necrosis factor alpha in an endotoxemic baboon model. Circ. Shock 38: 75-83, 1992.
11. Eskandari, M. K., G. Bolgos, C. Miller, T. Nguyen, L. E. DeForge, and D. G. Remick. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J. Immunol. 148: 2724-2729, 1992.
12. Fahey, T. J., III, T. Yoshioka, T. Shires, and G. A. Fantini. The role of tumor necrosis factor and nitric oxide in the acute cardiovascular response to endotoxin. Ann. Surg. 223: 63-69, 1996.
13. Feuerstein, G., and J. M. Hallenbeck. Prostaglandins, leukotrienes, and platelet-activating factor in shock. Annu. Rev. Pharmacol. Toxicol. 27: 301-313, 1987.
14. Forstermann, U., I. Gath, P. Schwarz, E. I. Closs, and H. Kleinert. Isoforms of nitric oxide synthase. Properties, cellular distribution and expressional control. Biochem. Pharmacol. 50: 1321-1332, 1995.
15. Geller, D. A., P. D. Freeswick, D. Nguyen, A. K. Nussler, M. Di Silvio, R. A. Shapiro, S. C. Wang, R. L. Simmons, and T. R. Billiar. Differential induction of nitric oxide synthase in hepatocytes during endotoxemia and the acute-phase response. Arch. Surg. 129: 165-171, 1994.
16. Greenberg, S. S., J. Xie, K. O. Joseph, J. Kolls, and W. Summer. In vivo administration of endotoxin and tumor necrosis factor-alpha produce different effects on constitutive and inducible nitric oxide synthase activity in rat neutrophils and aorta ex vivo. Proc. Soc. Exp. Biol. Med. 208: 199-208, 1995.
17. Greenberg, S., J. Xie, Y. Wang, B. Cai, J. Kolls, S. Nelson, A. Hyman, W. R. Summer, and H. Lippton. Tumor necrosis factor-alpha inhibits endothelium-dependent relaxation. J. Appl. Physiol. 74: 2394-2403, 1993.
18. Heuer, H. O., G. Letts, and C. J. Meade. Tumor necrosis factor (TNF) and endotoxin prime effects of PAF in vivo. J. Lipid Mediators 2, Suppl.: S101-S108, 1990.
19. Kerwin, J. F., Jr., J. R. Lancaster, Jr., and P. F. Feldman. Nitric oxide: a new paradigm for second messengers. J. Med. Chem. 38: 4343-4362, 1995.
20. G-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc. Natl. Acad. Sci. USA 87: 3629-3632, 1990.
21. Kolls, J. K., J. Xie, D. Lei, S. Greenberg, W. R. Summer, and S. Nelson. Differential effects of in vivo ethanol on LPS-induced TNF and nitric oxide production in the lung. Am. J. Physiol. 268 (Lung Cell. Mol. Physiol. 12): L991-L998, 1995.
22. McGuinness, O. P., D. B. Lacy, I. Ejiofer, and G. T. Bagby. Hepatic release of tumor necrosis factor in the endotoxin-treated conscious dog. Shock 5: 344-348, 1996.
23. Myers, P. R., Q. Zhong, J. J. Jones, M. A. Tanner, H. R. Adams, and J. L. Parker. Release of EDRF and NO in ex vivo perfused aorta: inhibition by in vivo E. coli endotoxemia. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H955-H961, 1995.
24. Neilson, I. R., K. A. Neilson, E. J. Yunis, and M. I. Rowe. Failure of tumor necrosis factor to produce hypotensive shock in the absence of endotoxin. Surgery 106: 439-443, 1989.
25. Petros, A., D. Bennett, and P. Vallance. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338: 1557-1558, 1991.
26. Schotanus, K., G. M. Holtkamp, N. Van Rooijen, F. J. H. Tilders, and F. Berkenbosch. Circulating tumor necrosis factor-α does not mediate endotoxin-induced hypothermia in rats. Am. J. Physiol. 268 (Regulatory Integrative Comp. Physiol. 37): R989-R996, 1995.
27. Schröder, M., W. Risau, R. Hallman, P. Gautschi, and P. Bohlen. Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc. Natl. Acad. Sci. USA 84: 5277-5283, 1987.
28. Szabo, C., C. C. Wu, J. A. Mitchell, S. S. Gross, C. Thiemermann, and J. R. Vane. Platelet-activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide. Circ. Res. 73: 991-999, 1993.
29. G-nitro-L-arginine on shock induced by endotoxin and by platelet activating factor in dogs. Eur. J. Pharmacol. 250: 465-467, 1993.
30. Thiemermann, C., C. C. Wu, C. Szabo, M. Perretti, and J. R. Vane. Role of tumour necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock. Br. J. Pharmacol. 110: 177-182, 1993.
31. Wang, P., Z. F. Ba, and I. H. Chaudry. Endothelium-dependent relaxation is depressed at the macro- and microcirculatory levels during sepsis. Am. J. Physiol. 269 (Regulatory Integrative Comp. Physiol. 38): R988-R994, 1995.
32. Wright, C. E., D. D. Rees, and S. Moncada. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc. Res. 26: 48-57, 1992.
33. Xie, J., J. Kolls, G. Bagby, and S. S. Greenberg. Independent suppression of nitric oxide and TNF alpha in the lung of conscious rats by ethanol. FASEB J. 9: 253-261, 1995.
34. Yoshizumi, M., M. A. Perrella, J. C. Burnett, Jr., and M. E. Lee. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ. Res. 73: 205-209, 1993.